231 filings
Page 8 of 12
8-K
8ecnjvp
7 Nov 18
Axovant Announces Second Fiscal Quarter 2018 Financial Results and Corporate Updates
12:00am
8-K
y2tfk8
2 Oct 18
Departure of Directors or Certain Officers
4:16pm
CT ORDER
qy0sw5loubsn0ch
28 Aug 18
Confidential treatment order
12:00am
8-K
6bqogbqzu l15xh5
17 Aug 18
Submission of Matters to a Vote of Security Holders
4:27pm
S-8
cxfidjja5q3x15n
16 Aug 18
Registration of securities for employees
5:23pm
8-K
1ky7 nbqv
7 Aug 18
Axovant Announces First Fiscal Quarter 2018 Financial Results and Corporate Update
12:00am
8-K
46gft3zw
9 Jul 18
Entry into a Material Definitive Agreement
6:13am
8-K
dc9o5g
22 Jun 18
Entry into a Material Definitive Agreement
5:28pm
424B5
r0hbl0zio22ss1
22 Jun 18
Prospectus supplement for primary offering
5:28pm
DEF 14C
va1ids794lih hy
18 Jun 18
Information statement
7:00am
PRE 14C
n9v22
7 Jun 18
Preliminary information
6:03am
8-K
huu a31bdjde
6 Jun 18
Axovant Licenses Investigational Gene Therapy for Parkinson’s Disease from Oxford BioMedica and Announces Key Leadership Team Addition
6:02am
8-K/A
lpk4l4efq4v u3
14 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K/A
3v5ijywfx
7 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
mbxd1a69y qsu4g01t
14 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K/A
z8sjlk
9 Jan 18
Other Events
12:00am